Synthesizing Pharmaceuticals Using Containerless Processing (IN-10-011)
Argonne National Laboratory, Illinois, United States
A process by which amorphous and nanophase pharmaceutical compounds can be synthesized without the use of a container, thus avoiding potential contamination.
Primary Application Area: Pharmaceuticals & Personal Care
Technology Development Status: Prototype
Technology Readiness Level: TRL 5
FIGURES OF MERIT
Value Proposition: Competing processes suppress nucleation of crystals by modifying the drug formulation, adding glassy polymer binders that disperse and trap molecules in a disorder form. Our method directly avoids nucleation, without binders, a drug can be formulated in higher purity doses creating drug tablets that provide maximum benefit to the patient.
Organization Type: Academic/Gov Lab
Showcase Booth #: 707
GOVT/EXTERNAL FUNDING SOURCES
Government Funding/Support to Date:
Primary Sources of Funding: Federal Grant
Looking for: Both Funding and Development Partners